Relevant bibliographies by topics / Vaccination – Immunologie

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Vaccination – Immunologie'

Author: Grafiati
Published: 1 February 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Vaccination – Immunologie.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Vaccination – Immunologie"

1

Confer, A. W., R. J. Panciera, M. J. Gentry, and R. W. Fulton. "Immunologie response to Pasteurella haemolytica and resistance against experimental bovine pneumonic pasteurellosis, induced by bacterins in oil adjuvants." American Journal of Veterinary Research 48, no. 2 (1987): 163–68. https://doi.org/10.2460/ajvr.1987.48.02.163.

Full text
Abstract:
SUMMARY Immunogenicity of and protection afforded by Pasteurella haemolytica bacterins were studied in calves. Bacterins contained an aluminum hydroxide in gel (alh) adjuvant or one of the following oil-in-water adjuvants: Freund's complete adjuvant (fca), Freund's incomplete adjuvant (fia), and trehalose dimycolate (tdm). On days 0 and 7, calves were vaccinated with phosphate-buffered saline solution (pbss), a bacterin, or live P haemolytica. Transthoracic intrapulmonic challenge exposure was done on day 21. In 3 experiments, there were no significant (P > 0.05) differences between lung le
APA, Harvard, Vancouver, ISO, and other styles
2

Bazin, Hervé. "L’histoire des vaccinations. 2e partie : des vaccins pastoriens aux vaccins modernes." Bulletin de la Société Française d'Histoire de la Médecine et des Sciences Vétérinaires 13, no. 1 (2013): 45–63. https://doi.org/10.3406/bhsv.2013.1146.

Full text
Abstract:
Cette présentation concerne la mise en route des vaccins à virulence atténuée par Pasteur et son équipe, donnant l’espoir d’obtenir un vaccin pour chaque maladie infectieuse. De nombreuses techniques ont été mises en oeuvre : vaccins chimiques, sérothérapie, séro-vaccination, vaccins tués (microbes) ou inactivés (virus), auto-vaccins, anatoxines, irradiation de parasites… pour les vaccins de première génération. La naissance de la biologie moléculaire et du génie génétique en microbiologie et en immunologie a conduit à une explosion de vaccins OGM dont les premiers exemples sont le vaccin hépa
APA, Harvard, Vancouver, ISO, and other styles
3

Olsen, S. C., and C. Johnson. "Immune Responses and Safety after Dart or Booster Vaccination of Bison with Brucella abortus Strain RB51." Clinical and Vaccine Immunology 19, no. 5 (2012): 642–48. http://dx.doi.org/10.1128/cvi.00033-12.

Full text
Abstract:
ABSTRACTOne alternative for management of brucellosis in Yellowstone National Park bison (Bison bison) is vaccination of calves and yearlings. AlthoughBrucella abortusstrain RB51 vaccination protects bison against experimental challenge, the effect of booster vaccinations was unknown. This study characterized immunologic responses after dart or booster vaccination of bison withBrucella abortusstrain RB51. In two studies, 8- to 10-month-old female bison were inoculated with saline (n= 14), hand vaccinated with 1.1 × 1010to 2.0 × 1010CFU of RB51 (n= 21), or dart vaccinated with 1.8 × 1010CFU of
APA, Harvard, Vancouver, ISO, and other styles
4

Ridolfi, Irene, Luca Lo Sardo, Stefania Nicola, et al. "MAURIVAX: A Vaccination Campaign Project in a Hospital Environment for Patients Affected by Autoimmune Diseases and Adult Primary Immunodeficiencies." Vaccines 11, no. 10 (2023): 1579. http://dx.doi.org/10.3390/vaccines11101579.

Full text
Abstract:
Background: Patients with autoimmune diseases (ADs) and primary immunodeficiencies (PIDs) are characterized by an increased risk of noninvasive and widespread infections as they are considered frail patients. In addition, many flares of the underlying disease are reported after routine vaccinations. To date, the vaccination rate in these two populations is suboptimal. According to the latest guidelines, targeted interventions are needed, such as strengthening the network of vaccination activities. Our project aimed to propose a pilot network for carrying out the recommended vaccinations in fra
APA, Harvard, Vancouver, ISO, and other styles
5

Rosenblat, Todd L., Mark G. Frattini, Suzanne M. Chanel, et al. "Phase II Trial of WT1 Analog Peptide Vaccine in Patients with Acute Myeloid Leukemia (AML) in Complete Remission (CR)." Blood 120, no. 21 (2012): 3624. http://dx.doi.org/10.1182/blood.v120.21.3624.3624.

Full text
Abstract:
Abstract Abstract 3624 WT1 is a transcription factor which has been implicated in leukemogenesis and has been used as a marker of minimal residual disease (MRD). We previously demonstrated the feasibility of vaccinating AML patients in CR with a multivalent WT1 peptide vaccine and inducing immune responses. In an effort to further explore the safety and efficacy of this approach, we are conducting a Phase II study in which the vaccine is administered to AML patients in first CR and who completed all planned postremission chemotherapy. Eligible patients had WT1 transcript detectable by RT-PCR.
APA, Harvard, Vancouver, ISO, and other styles
6

Gates, Dana M., Steven A. Cohen, Kelly Orr, and Aisling R. Caffrey. "Pharmacist-Administered Influenza Vaccination in Children and Corresponding Regulations." Vaccines 10, no. 9 (2022): 1410. http://dx.doi.org/10.3390/vaccines10091410.

Full text
Abstract:
In our retrospective cohort study, we evaluated trends in pharmacist-administered pediatric influenza vaccination rates in the United States and corresponding state-level pharmacist pediatric vaccination authorization models, including minimum age requirements, vaccination protocols, and/or prescription requirements. An administrative health claims database was used to capture influenza vaccinations in children less than 18 years old with 1 year of continuous enrollment and joinpoint regression was used to assess trends. Of the 3,937,376 pediatric influenza vaccinations identified over the stu
APA, Harvard, Vancouver, ISO, and other styles
7

Buckwalter, Matthew, and Pramod Srivastava. "Form of antigen dictates immunity: Irradiated cell vs. whole cell lysate vaccination (48.16)." Journal of Immunology 178, no. 1_Supplement (2007): S77. http://dx.doi.org/10.4049/jimmunol.178.supp.48.16.

Full text
Abstract:
Abstract The context in which antigen is perceived by the immune system dictates the quality of the ensuing immune response, which can range from tolerance to lasting immunity. In the current report we investigated the effects of vaccinating mice with antigen in two separate contexts, namely: Irradiated cells, or whole cell lysates. Using the MethA tumor model we observed that although a single vaccination with irradiated MethA cells leads to immunity in BALB/c mice, vaccination with the same cell equivalents of whole cell lysate does not. These results were surprising in light of the substant
APA, Harvard, Vancouver, ISO, and other styles
8

Huppke, L., C. Gebhardt, L. Grümme, et al. "AB1326 DIFFERENCES IN ADVERSE EVENTS EXPERIENCED BY INDIVIDUALS WITH INFLAMMATORY RHEUMATIC DISEASES AND HEALTHY INDIVIDUALS AFTER SARS-CoV-2 VACCINATION." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 1892.1–1892. http://dx.doi.org/10.1136/annrheumdis-2023-eular.497.

Full text
Abstract:
BackgroundSince individuals with inflammatory rheumatic diseases (IRDs) were excluded from the SARS-CoV-2 vaccination trials (1), uncertainty on the tolerability of the vaccines in this population was high. This caused a lower willingness to be vaccinated compared to the general population. Gaining more information on vaccine reaction in this population is critical.ObjectivesThe aim of the study was to improve knowledge of the tolerability of SARS-CoV-2 vaccination in patients with IRD and to identify potential specific risks of this population by comparison with a healthy cohort.MethodsIRD pa
APA, Harvard, Vancouver, ISO, and other styles
9

Wu, Yufei, Huanjie Li, Yangyang Wang, et al. "Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines." Vaccines 10, no. 5 (2022): 647. http://dx.doi.org/10.3390/vaccines10050647.

Full text
Abstract:
As the third year of the global COVID-19 pandemic, vaccination remains the most effective tool against infections and symptomatic illness. Comprehension regarding immunity to SARS-CoV-2 is limited, and the durability of immune responses after vaccination is currently not clear. In this study, we randomly collected 395 questionnaires to analyze the current state of COVID-19 vaccination. At the same time, the serum of 16 individuals who had received two doses of the COVID-19 vaccine were collected at different times before and after the booster vaccination. We analyzed the dynamic changes of SAR
APA, Harvard, Vancouver, ISO, and other styles
10

Robinson, Stacie J., Michelle M. Barbieri, Samantha Murphy, et al. "Model recommendations meet management reality: implementation and evaluation of a network-informed vaccination effort for endangered Hawaiian monk seals." Proceedings of the Royal Society B: Biological Sciences 285, no. 1870 (2018): 20171899. http://dx.doi.org/10.1098/rspb.2017.1899.

Full text
Abstract:
Where disease threatens endangered wildlife populations, substantial resources are required for management actions such as vaccination. While network models provide a promising tool for identifying key spreaders and prioritizing efforts to maximize efficiency, population-scale vaccination remains rare, providing few opportunities to evaluate performance of model-informed strategies under realistic scenarios. Because the endangered Hawaiian monk seal could be heavily impacted by disease threats such as morbillivirus, we implemented a prophylactic vaccination programme. We used contact networks
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Vaccination – Immunologie"

1

Baey, Camille. "Etude de l’efficacité et des mécanismes de la présentation croisée d’antigènes cellulaires tumoraux intacts par les cellules dendritiques." Thesis, Paris 5, 2013. http://www.theses.fr/2013PA05T054/document.

Full text
Abstract:
Les cellules dendritiques (DC) sont spécialisées dans la capture, l’apprêtement et la présentation des antigènes. Elles ont développé une voie spécifique de présentation, la présentation croisée, leur permettant d’internaliser des antigènes exogènes, de les digérer et de les associer aux molécules du CMH de classe I afin de les présenter aux lymphocytes T CD8+. La présentation croisée est essentielle à la présentation d’antigènes qui ne sont pas synthétisés directement dans les DC (antigènes du soi, de tumeurs, de microorganismes n’infectant pas les DC) et donc à l’établissement de réponses T
APA, Harvard, Vancouver, ISO, and other styles
2

Beignon, Anne-Sophie. "Exploitation du système immunitaire de la peau pour l'administration non-invasive de vaccins." Université Louis Pasteur (Strasbourg) (1971-2008), 2002. http://www.theses.fr/2002STR13068.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Leite, Pereira Adrien. "Découverte de marqueurs immunologiques permettant d’évaluer l’innocuité des nouveaux vaccins." Thesis, Université Paris-Saclay (ComUE), 2018. http://www.theses.fr/2018SACLS177.

Full text
Abstract:
La vaccination est souvent mal perçue par la population générale. Pour rassurer cette dernière, il serait intéressant de créer une plateforme vaccinale pouvant prédire, in vitro, les risques associés à la prise d’un vaccin. L’objectif de cette thèse est de mettre au point les prémices de cette plateforme. Le principe est simple: obtenir la signature inflammatoire d’un vaccin candidat pour évaluer son innocuité. Pour cela, cette signature sera comparée à celles obtenues par des vaccins actuellement sur le marché ou induites par des pathogènes.Durant cette thèse, nous avons sélectionné une liste
APA, Harvard, Vancouver, ISO, and other styles
4

Mahé, Brice. "Etude de la vaccination par la voie transcutanée : modèles expérimentaux et études cliniques." Paris 6, 2007. http://www.theses.fr/2007PA066470.

Full text
Abstract:
La récente implication de DCs cutanées dans le mécanisme de présentation croisée et l’induction de réponses T CD8+ suggère que la vaccination transcutanée soit une voie adéquate favorisant les réponses immunes cellulaires. D’une part, le modèle murin nous a permis d’établir in vivo que suite à l’application transcutanée de nanoparticules (40/200 Nm) un afflux de ces nanoparticules atteignait le ganglion drainant la zone traitée. D’autre part, l’utilisation de vecteurs viraux modifiés, comme le MVA (Modified Virus Ankara), nous a permis d’établir que des immunogènes de taille plus importante (≈
APA, Harvard, Vancouver, ISO, and other styles
5

Dupuy-Papin, Catherine. "Vaccination anti-papillomavirus : réponse systémique et vaginale contre la protéine majeure de capside." Tours, 1998. http://www.theses.fr/1998TOUR3813.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gross, David Alexandre. "Identification et optimisation d'antigènes tumoraux en vue d'une vaccination antitumorale." Paris 6, 2001. http://www.theses.fr/2001PA066432.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Çobanoglu, Özmen. "Contribution de la sénescence cellulaire à la vaccination anti-tumorale chez l’individu âgé." Electronic Thesis or Diss., Université de Lille (2022-....), 2023. http://www.theses.fr/2023ULILS083.

Full text
Abstract:
Le déclin du système immunitaire naturellement lié à l'âge - appelé immunosénescence - contribue à la moindre efficacité des vaccins chez les personnes âgées. La sénescence cellulaire est caractérisée par une inflammation chronique de bas grade. Les cellules sénescentes s'accumulent avec l'âge et sont résistantes à la mort cellulaire, notamment du fait de l'augmentation de l'expression des membres de la famille Bcl-2. Les cellules sénescentes produisent de nombreux facteurs inflammatoires et des immunomodulateurs, ce qui contribue à l'expression de leurs fonctions délétères. Ces cellules cause
APA, Harvard, Vancouver, ISO, and other styles
8

Deutscher, Mathieu Meyer Gilles. "Infection expérimentale par le virus respiratoire syncytial bovin étude des interactions entre la vaccination et l'évolution du virus /." [S.l.] : [s.n.], 2007. http://oatao.univ-toulouse.fr/1798/1/celdran_1798.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Haddad, Nadia. "Vaccination du chien contre la rage : fabrication et contrôles d'un vaccin à virus inactivé préparé sur encéphale d'agneau : étude comparée de l'activité de deux vaccins sur des chiens du terrain en Tunisie." Lyon 1, 1985. http://www.theses.fr/1985LYO10122.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sagodira, Serge. "Vaccination génétique par voie nasale contre la cryptosporidiose : étude de la réponse immunitaire chez la souris et de la protection dans un modèle caprin." Tours, 1998. http://www.theses.fr/1998TOUR3808.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Vaccination – Immunologie"

1

Symposium in Immunology (7th 1997?). Symposium in Immunology VII: Vaccination. Springer, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1956-, Zhang Jingwu, and Cohen Irun R, eds. T-cell vaccination. Nova Biomedical Books, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

E, Kaufmann S. H., ed. Novel vaccination strategies. Wiley-VCH, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ada, G. L. Vaccination: The facts, the fears, the future. Allen & Unwin, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

J, Raus, ed. T cell vaccination and autoimmune disease. Springer-Verlag, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Foged, Camilla. Subunit vaccine delivery. Edited by Rades Thomas author, Perrie Yvonne author, and Hook Sarah author. Springer, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Alejandro, Schudel, Lombard Michel, and International Office of Epizootics, eds. Control of infectious animal diseases by vaccination: Buenos Aires, Argentina, 13-16 April, 2005 ; proceedings of a conference organized by the World Organisation for Animal Health-OIE. Karger, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Alejandro, Schudel, and Lombard Michel, eds. Control of infectious animal diseases by vaccination: Buenos Aires, Argentina, 13-16 April, 2005. Karger, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

International, Meeting on the History of Vaccinology (1995 Marnes-la Coquette Hauts-de-Seine). Vaccinia, vaccination, vaccinology: Jenner, Pasteur, and their successors. Elsevier, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Aronova, E. A. Immunitet: Teorii︠a︡, filosofii︠a︡ i ėksperiment : ocherki iz istorii immunologii XX veka. KomKn., 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Vaccination – Immunologie"

1

Catchpole, Brian, and Harm HogenEsch. "Vaccination." In Day's Veterinary Immunology, 3rd ed. CRC Press, 2023. http://dx.doi.org/10.1201/9781003310969-13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Klimov, Vladimir V. "Vaccination." In From Basic to Clinical Immunology. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-03323-1_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jaspreet, Dhami, Wang Vivian, Wang Ziwei, Pham Brittney, Yabuno Jamie, and Joseph Yusin. "Vaccination." In Absolute Allergy and Immunology Board Review. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-12867-7_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Durrant, L. G., I. Spendlove, and R. A. Robins. "Anti-idiotypic vaccination." In Cancer Immunology. Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-017-0963-7_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rijkers, G. T. "17 Vaccins en vaccinatie." In Immunologie. Bohn Stafleu van Loghum, 2009. http://dx.doi.org/10.1007/978-90-313-6528-9_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rijkers, G. T., and F. G. M. Kroese. "Vaccins en vaccinatie." In Leerboek immunologie. Bohn Stafleu van Loghum, 2023. http://dx.doi.org/10.1007/978-90-368-2817-8_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rijkers, G. T. "Vaccins en vaccinatie." In Leerboek immunologie. Bohn Stafleu van Loghum, 2016. http://dx.doi.org/10.1007/978-90-368-0258-1_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cohen, Noah D., and Angela I. Bordin. "Principles of Vaccination." In Equine Clinical Immunology. John Wiley & Sons, Inc., 2015. http://dx.doi.org/10.1002/9781119086512.ch28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sharapova, Svetlana O. "Fever After DPT Vaccination." In Pediatric Immunology. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-21262-9_49.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Huizinga, T. W. J., and L. G. Visser. "15 Vaccinatie en immunomodulatie." In Medische immunologie. Bohn Stafleu van Loghum, 2016. http://dx.doi.org/10.1007/978-90-368-1613-7_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Vaccination – Immunologie"

1

Telgen, Maaike C., M. G. J. Brusse-Keizer, G. T. Rijkers, et al. "Immunologic Responses In COPD Patients: The Annual Influenza Vaccination." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2270.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pamar, P., K. Krolikowski, D. Rudym, et al. "Immunologic Effects of SARS-CoV-2 Vaccination in Lung Transplant Recipients." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Garrido, Greta, Brett Schrand, Agata Levay, et al. "Abstract B26: Prorapeutic vaccination against shared antigens induced in future tumors." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 17-20, 2019; Boston, MA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm19-b26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brody, Joshua D. "Abstract IA32: Improving checkpoint blockade for lymphoma with Flt3L-primed in situ vaccination." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; October 1-4, 2017; Boston, MA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/2326-6074.tumimm17-ia32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kim, Ha, Keejong Hong, Byung Cheol Ahn, Jung Sun Yum, and Hyewon Youn. "Abstract B25: Visualization of immune response to Hepatitis B vaccination by in vivo mouse imaging." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; October 20-23, 2016; Boston, MA. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/2326-6074.tumimm16-b25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Carpanese, D., I. Montagner, A. Dalla Pietà, et al. "P09.03 Hyaluronic acid as a new immunologic adjuvant in cancer: design of effective preventive and therapeutic vaccination strategies for HER2/neu-positive breast tumors." In iTOC8 – the 8th Leading International Cancer Immunotherapy Conference in Europe, 8–9 October 2021, Virtual Conference. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/jitc-2021-itoc8.53.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Marron, Thomas, Nina Bhardwaj, Elizabeth Crowley, et al. "Abstract IA03: Turning a tumor into a vaccine factory: In situ vaccination for low-grade lymphoma." In Abstracts: AACR Special Conference: Tumor Immunology and Immunotherapy: A New Chapter; December 1-4, 2014; Orlando, FL. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/2326-6074.tumimm14-ia03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Witt, Kristina, Maarten Alexander Ligtenberg, Laura Conti, et al. "Abstract A77: Cripto-1 vaccination elicits protective immune response to metastatic breast cancer and breast cancer stem cells." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; October 1-4, 2017; Boston, MA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/2326-6074.tumimm17-a77.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Schreiber, Taylor H., Louis Gonzalez, Dietlinde Wolf, Maria Bodero, and Eckhard R. Podack. "Abstract A38: T cell costimulation by TNFRSF4, TNFRSF18, and TNFRSF25 in the context of vaccination." In Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-a38.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Andersen, Brian M., G. Elizabeth Pluhar, Charles E. Seiler, et al. "Abstract B32: Preclinical testing of three immune adjuvants in vaccination therapy for invasive canine meningioma." In Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-b32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Vaccination – Immunologie' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography